Amicus Therapeutics Ownership | Who Owns Amicus Therapeutics?

Overview Forecast RevenueFinancials Chart Transcripts

Amicus Therapeutics Ownership Summary

Amicus Therapeutics is owned by 103.64% institutional investors, 0.72% insiders. Vanguard group is the largest institutional shareholder, holding 9.60% of FOLD shares. Vanguard Health Care Inv is the top mutual fund, with 6.78% of its assets in Amicus Therapeutics shares.

FOLD Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Amicus Therapeutics	103.64%	0.72%	-4.36%
Sector	Healthcare Stocks	488.17%	11.08%	-399.26%
Industry	Biotech Stocks	306.59%	11.10%	-217.69%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vanguard group	29.26M	9.60%	$275.62M
Wellington management group llp	28.46M	9.34%	$268.11M
Blackrock funding, inc. /de	27.53M	8.94%	$157.76M
Blackrock	24.37M	8.05%	$241.77M
Avoro capital advisors	18.00M	5.84%	$103.14M
William blair investment management	14.64M	4.75%	$83.90M
Vestal point capital, lp	11.90M	3.86%	$68.19M
State street	10.36M	3.40%	$97.60M
Perceptive advisors	7.41M	2.41%	$42.48M
Jpmorgan chase	7.21M	2.37%	$67.96M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Palo alto investors lp	5.61M	6.84%	$32.15M
Prosight management, lp	3.48M	4.86%	$19.94M
Cm management	450.00K	3.79%	$4.24M
Vestal point capital, lp	11.90M	3.59%	$68.19M
Avoro capital advisors	18.00M	1.81%	$103.14M
Perceptive advisors	7.41M	1.57%	$42.48M
Sphera funds management	990.72K	1.33%	$5.68M
Sovereign's capital management	355.61K	1.09%	$2.04M
Rice hall james & associates	2.76M	0.85%	$15.82M
Intrinsic edge capital management	673.90K	0.77%	$6.35M

Top Buyers

Holder	Shares	% Assets	Change
Vestal point capital, lp	11.90M	3.59%	7.63M
Wellington management group llp	28.46M	0.05%	4.50M
Norges bank	3.08M	0.00%	3.08M
Assenagon asset management	3.53M	0.03%	3.06M
Qube research	3.47M	0.02%	2.40M

Top Sellers

Holder	Shares	% Assets	Change
Perceptive advisors	7.41M	1.57%	-14.05M
Redmile group	1.19M	0.73%	-8.34M
Jpmorgan chase	7.21M	0.01%	-5.71M
Morgan stanley	4.99M	0.00%	-4.71M
American century companies	-	-	-3.90M

New Positions

Holder	Shares	% Assets	Change	Value
Norges bank	3.08M	0.00%	3.08M	$29.03M
M&g	1.88M	0.06%	1.88M	$11.31M
Susquehanna portfolio strategies	1.26M	0.16%	1.26M	$7.22M
Sphera funds management	990.72K	1.33%	990.72K	$5.68M
Intrinsic edge capital management	673.90K	0.77%	673.90K	$6.35M

Sold Out

Holder	Change
Quadrant capital group	-14.00
Federated hermes	-28.00
Capital performance advisors llp	-43.00
Cva family office	-43.00
Svb wealth	-44.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2025	279	-4.78%	319,193,520	4.06%	103	1.04%	152	0.66%	81	-3.57%
Mar 31, 2025	293	-2.98%	309,463,718	1.44%	100	1.00%	152	2.01%	83	-17.82%
Dec 31, 2024	144	-52.32%	151,685,331	-50.57%	49	0.49%	60	-59.46%	59	-35.16%
Sep 30, 2024	300	12.78%	306,793,850	-2.57%	100	0.93%	149	5.67%	90	20.00%
Jun 30, 2024	266	1.53%	314,899,506	-0.72%	103	0.95%	141	6.01%	75	-6.25%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Health Care Inv	20.89M	6.78%	-
Vanguard Total Stock Mkt Idx Inv	9.51M	3.08%	-200.71K
Vanguard US Total Market Shares ETF	9.38M	3.05%	10.28K
Vanguard Small Cap Index	7.47M	2.42%	-48.88K
iShares Russell 2000 ETF	6.55M	2.12%	-124.42K
Macquarie Small Cap Core I	5.62M	1.82%	614.64K
Delaware Small Cap Core I	5.13M	1.73%	-31.80K
SPDR® S&P Biotech ETF	5.04M	1.64%	124.19K
Janus Henderson Opportunistic Alpha MA	4.58M	1.54%	4.58M
Janus Henderson US Opportunistic Alpha	4.58M	1.54%	-565.02K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Feb 19, 2025	Campbell Bradley L	President and CEO	Sell	$4.00K
Dec 02, 2024	Campbell Bradley L	President and CEO	Sell	$75.12K
Nov 06, 2024	Campbell Bradley L	President and CEO	Sell	$98.80K
Nov 01, 2024	Campbell Bradley L	President and CEO	Sell	$85.96K
Oct 01, 2024	Campbell Bradley L	President and CEO	Sell	$79.49K

Insider Transactions Trends

Date	Buy	Sell
2025 Q2	-	-
2025 Q1	-	1
2024 Q4	-	4
2024 Q3	-	4
2024 Q2	-	3

FOLD Ownership FAQ

Who Owns Amicus Therapeutics?

Amicus Therapeutics shareholders are primarily institutional investors at 103.64%, followed by 0.72% insiders and -4.36% retail investors. The average institutional ownership in Amicus Therapeutics's industry, Biotech Stocks , is 306.59%, which Amicus Therapeutics falls below.

Who owns the most shares of Amicus Therapeutics?

Amicus Therapeutics’s largest shareholders are Vanguard group (29.26M shares, 9.60%), Wellington management group llp (28.46M shares, 9.34%), and Blackrock funding, inc. /de (27.53M shares, 8.94%). Together, they hold 27.88% of Amicus Therapeutics’s total shares outstanding.

Does Blackrock own Amicus Therapeutics?

Yes, BlackRock owns 8.05% of Amicus Therapeutics, totaling 24.37M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 241.77M$. In the last quarter, BlackRock increased its holdings by 1.52M shares, a 6.66% change.

Who is Amicus Therapeutics’s biggest shareholder by percentage of total assets invested?

Palo alto investors lp is Amicus Therapeutics’s biggest shareholder by percentage of total assets invested, with 6.84% of its assets in 5.61M Amicus Therapeutics shares, valued at 32.15M$.

Who is the top mutual fund holder of Amicus Therapeutics shares?

Vanguard Health Care Inv is the top mutual fund holder of Amicus Therapeutics shares, with 6.78% of its total shares outstanding invested in 20.89M Amicus Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools